Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


13.11.2017

1 AIDS
2 Am J Gastroenterol
1 Arch Virol
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
3 Hepatology
4 J Hepatol
1 J Med Virol
1 J Pediatr
7 J Viral Hepat
2 J Virol
1 Lancet
7 PLoS One
1 Virology
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.
    AIDS. 2017;31:2483-2492.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. SOLLIMA S, Milazzo L, Antinori S, Galli M, et al
    Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication.
    Am J Gastroenterol. 2017;112:1753-1754.
    PubMed     Text format    

  3. LIU X, Shen JJ, Lee JL, Yoo JW, et al
    Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.
    Am J Gastroenterol. 2017;112:1749.
    PubMed     Text format    


    Arch Virol

  4. GORI A, Gheorgita S, Spinu C, Pinzaru I, et al
    Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova.
    Arch Virol. 2017 Nov 8. doi: 10.1007/s00705-017-3632.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  5. MOSER S, Kozbial K, Laferl H, Schutz A, et al
    Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.
    Eur J Gastroenterol Hepatol. 2017 Nov 8. doi: 10.1097/MEG.0000000000001027.
    PubMed     Text format     Abstract available


    Gastroenterology

  6. DEBES JD, van Tilborg M, Groothuismink ZMA, Hansen BE, et al
    Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36295.
    PubMed     Text format     Abstract available


    Hepatology

  7. JENG WJ, Chen YC, Chien RN, Sheen IS, et al
    Incidence and predictors of HBsAg seroclearance after cessation of nucleos(t)ide analogue therapy in HBeAg negative chronic hepatitis B.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29640.
    PubMed     Text format     Abstract available

  8. KHANOVA E, Wu R, Wang W, Yan R, et al
    Pyroptosis by Caspase11/4-Gasdermin-D Pathway in Alcoholic Hepatitis.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29645.
    PubMed     Text format     Abstract available

  9. SIKAVI C, Chen PH, Lee AD, Saab EG, et al
    Hepatitis C and Human Immunodeficiency Virus Co-Infection in the Era of Direct-Acting Antiviral Agents: No Longer A Difficult to Treat Population.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29642.
    PubMed     Text format     Abstract available


    J Hepatol

  10. JANSSEN HLA, Brunetto MR, Kim YJ, Ferrari C, et al
    Safety, Efficacy and Pharmacodynamics of Vesatolimod (GS-9620) in Virally-Suppressed Patients with Chronic Hepatitis B.
    J Hepatol. 2017 Nov 2. pii: S0168-8278(17)32408.
    PubMed     Text format     Abstract available

  11. CARRIERI MP, Protopopescu C, Marcellin F, Wittkop L, et al
    The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients.
    J Hepatol. 2017 Nov 2. pii: S0168-8278(17)32406.
    PubMed     Text format    

  12. ALAVI M, Janjua NZ, Chong M, Grebely J, et al
    The contribution of alcohol-use disorder to decompensated cirrhosis among people with hepatitis C: an international study.
    J Hepatol. 2017 Oct 26. pii: S0168-8278(17)32398.
    PubMed     Text format     Abstract available

  13. OSSEMAN Q, Gallucci L, Au S, Cazenave C, et al
    The chaperone dynein LL1 mediates cytoplasmic transport of empty and mature hepatitis B virus capsids.
    J Hepatol. 2017 Nov 4. pii: S0168-8278(17)32424.
    PubMed     Text format     Abstract available


    J Med Virol

  14. ISHIGAMI M, Hayashi K, Honda T, Kuzuya T, et al
    Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93.
    J Med Virol. 2017 Nov 7. doi: 10.1002/jmv.24978.
    PubMed     Text format     Abstract available


    J Pediatr

  15. BARRITT AS 4TH, Lee B, Runge T, Schmidt M, et al
    Increasing Prevalence of Hepatitis C among Hospitalized Children Is Associated with an Increase in Substance Abuse.
    J Pediatr. 2017 Oct 26. pii: S0022-3476(17)31189.
    PubMed     Text format     Abstract available


    J Viral Hepat

  16. CHEN DS, Hamoudi W, Mustapha B, Layden J, et al
    Strategies to manage hepatitis C virus infection disease burden-Volume 4.
    J Viral Hepat. 2017;24 Suppl 2:44-63.
    PubMed     Text format     Abstract available

  17. SALMON-CERON D, Mondelli MU, Maticic M, Arends JE, et al
    The success of HCV cure: every rose has its thorn.
    J Viral Hepat. 2017 Nov 7. doi: 10.1111/jvh.12823.
    PubMed     Text format     Abstract available

  18. BHARDWAJ N, Ragonnet-Cronin M, Murrell B, Chodavarapu K, et al
    Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens.
    J Viral Hepat. 2017 Nov 7. doi: 10.1111/jvh.12825.
    PubMed     Text format     Abstract available

  19. DORE GJ, Hatzakis A, Negro F, Waked I, et al
    Estimating HCV disease burden-volume 4 (editorial).
    J Viral Hepat. 2017;24 Suppl 2:4-7.
    PubMed     Text format     Abstract available

  20. CHAN HLY, Chen CJ, Omede O, Al Qamish J, et al
    The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4.
    J Viral Hepat. 2017;24 Suppl 2:25-43.
    PubMed     Text format     Abstract available

  21. VUKOTIC R, Di Donato R, Conti F, Scuteri A, et al
    Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort.
    J Viral Hepat. 2017;24:13-16.
    PubMed     Text format     Abstract available

  22. MAAROUFI A, Vince A, Himatt SM, Mohamed R, et al
    Historical epidemiology of hepatitis C virus in select countries-volume 4.
    J Viral Hepat. 2017;24 Suppl 2:8-24.
    PubMed     Text format     Abstract available


    J Virol

  23. BRAHMS A, Mudhasani R, Pinkham C, Kota K, et al
    Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available

  24. SCHWEITZER CJ, Zhang F, Boyer A, Valdez K, et al
    N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
    J Virol. 2017 Nov 8. pii: JVI.01166-17. doi: 10.1128/JVI.01166.
    PubMed     Text format     Abstract available


    Lancet

  25. GARTNER C, Miller A, Bonevski B
    Extending survival for people with hepatitis C using tobacco dependence treatment.
    Lancet. 2017;390:2033.
    PubMed     Text format    


    PLoS One

  26. XIAO H, Shi M, Xie Y, Chi X, et al
    Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186660.
    PubMed     Text format     Abstract available

  27. KONERMAN MA, Lu D, Zhang Y, Thomson M, et al
    Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C.
    PLoS One. 2017;12:e0187344.
    PubMed     Text format     Abstract available

  28. RISALDE MA, Rivero-Juarez A, Romero-Palomo F, Frias M, et al
    Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar.
    PLoS One. 2017;12:e0186858.
    PubMed     Text format     Abstract available

  29. YANG Z, Jia M, Liu G, Hao H, et al
    Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model.
    PLoS One. 2017;12:e0187551.
    PubMed     Text format     Abstract available

  30. YOSHIOKA N, Deguchi M, Hagiya H, Kagita M, et al
    Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations.
    PLoS One. 2017;12:e0187661.
    PubMed     Text format     Abstract available

  31. LANINI S, Minosse C, Vairo F, Garbuglia A, et al
    A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017.
    PLoS One. 2017;12:e0185428.
    PubMed     Text format     Abstract available

  32. LOGGI E, Galli S, Vitale G, Di Donato R, et al
    Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.
    PLoS One. 2017;12:e0187755.
    PubMed     Text format     Abstract available


    Virology

  33. MANICKAM C, Martinot AJ, Jones RA, Varner V, et al
    Hepatic immunopathology during occult hepacivirus re-infection.
    Virology. 2017;512:48-55.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  34. GROSS MJ, Harter G, Backhus J, Zizer E, et al
    Direct-acting antiviral agents in the treatment of chronic Hepatitis C - "Real-life" experience from an academic centre and two specialized clinical practices.
    Z Gastroenterol. 2017 Nov 7. doi: 10.1055/s-0043-121892.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: